Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature

Journal of Acquired Immune Deficiency Syndromes

Volumn 31, Issue SUPPL. 3, 2002, Pages

  Ammassari, Adriana ^a   Trotta, Maria Paola ^b   Murri, Rita ^a   Castelli, Francesco ^c   Narciso, Pasquale ^b   Noto, Pasquale ^b   Vecchiet, Jacopo ^d   D'Arminio Monforte, Antonella ^e   Wu, Albert W ^f   Antinori, Andrea ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d UNIVERSITY OF CHIETI   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Adherence; Antiretroviral therapy; Compliance; HAART; HIV AIDS

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; CONFERENCE PAPER; DEMOGRAPHY; DEPRESSION; DOCTOR PATIENT RELATION; FAMILY; HEALTH CARE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ILLNESS BEHAVIOR; LYMPHOCYTE COUNT; MEDICAL LITERATURE; MEDLINE; MENTAL STRESS; METHODOLOGY; PATIENT COMPLIANCE; PATIENT SATISFACTION; PREDICTION; PRIORITY JOURNAL; PUBLICATION; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; SELF CONCEPT; SOCIAL ASPECT; SOCIAL SUPPORT; SUBSTANCE ABUSE; SYMPTOM;

EID: 0037114856     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200212153-00007     Document Type: Conference Paper

References (29)

1. Eldred LJ, Wu AW, Chaisson RE, et al. Adherence to antiretroviral and Pneumocystis prophylaxis in HIV disease. J Acquir Immune Defic Syndr 1998;18:117-25.
2. Mostashari F, Riley E, Selwyn PA, et al. Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:341-8.
3. Holzemer WL, Corless IB, Nokes KM, et al. Predictors of selfreported adherence in persons living with HIV disease. AIDS Patient Care STD 1999;13:185-97.
4. Haubrich RH, Little SJ, Currier JS, et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. AIDS 1999;13:1099-107.
5. Gordillo V, del Amo J, Soriano V, et al. Sociodemographic and psychologic variables influencing adherence to antiretroviral therapy. AIDS 1999;13:1763-9.
6. Singh N, Berman SM, Swindells S, et al. Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clin Infect Dis 1999;29:824-30.
7. Moatti JP, Carrieri MP, Spire B, et al. Adherence to HAART in French HIV-infected injecting drug users: The contribution of buprenorphine drug maintenance treatment. AIDS 2000;14:151-5.
8. Catz SL, Kelly JA, Bogart LM, et al. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol 2000;19:124-33.
9. Gifford AL, Bormann JE, Shively MJ, et al. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr 2000;23:386-95.
10. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30.
11. Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. AIDS Care 2000:12:255-66.
12. Murri R, Ammassari A, Gallicano K, et al. Patient-reported nonadherence to HAART is related to protease inhibitor levels. J Acquir Immune Defic Syndr 2000;24:123-8.
13. Gao X, Nau DP, Rosenbluth SA, et al. The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care 2000;12:387-98.
14. Kleeberger CA, Phair JP, Strathdee SA, et al. Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 2001;26:82-92.
15. Altice FL, Mostashari F, Friedland GH. Trust and acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr 2001;28:47-58.
16. Stone VE, Hogan JW, Schuman P, et al. Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: Survey of women in the HER study. J Acquir Immune Defic Syndr 2001;28:124-31.
17. Duran S, Spire B, Raffi F, et al. Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART. HIV Clin Trials 2001;2:38-45.
18. Ammassari A, Murri R, Pezzotti P et al. Self-reported symptoms and medications side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr 2001;28:445-9.
19. Wilson TE, Barron Y, Cohen M, et al. Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus. Clin Infect Dis 2002;34:529-34.
20. Mannheimer S, Friedland G, Matts J, et al. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis 2002;34:1115-21.
21. Gallant JE, Block DS. Adherence to antiretroviral regimens in HIV-infected patients: Results of a survey among physicians and patients. J Int Assoc Phys AIDS Care 1998;4:32-5.
22. Arnsten JH, Demas PA, Farzadegan H, et al. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-reported and electronic monitoring. Clin Infect Dis 2001;33:1417-23.
23. Hugen PW, Langebeek N, Burger DM, et al. Assessment of adherence to HIV protease inhibitors: Comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring. J Acquir Immune Defic Syndr 2002;30:324-34.
24. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 2000;14:357-66.
25. Liu H, Golin CE, Miller LG, et al. Comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 2001;134:968-77.
26. Nieuwkerk PT, Sprangers MAG, Burger DM, et al. Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study. Arch Intern Med 2001;161:1962-8.
27. Wilson IR, Tchetgen E, Spiegelman. Patterns of adherence with antiretroviral medications: An examination of between-medication differences. J Acquir Immune Defic Syndr 2001;28:259-63.
28. Murri R, Ammassari A, De Luca A, et al. Self-reported nonadherence with antiretroviral drugs predicts persistent condition. HIV Clin Trials 2001;2:323-9.
29. Carrieri P, Cailleton V, Le Moing V, et al. The dynamic of adherence to highly active antiretroviral therapy: Results from the French national APROCO cohort. J Acquir Immune Defic Syndr 2001;232-239.